Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 131Colonic Neoplasms 72Rectal Neoplasms 61Breast Neoplasms 61Stomach Neoplasms 37Pancreatic Neoplasms 31Squamous Cell Carcinoma of Head and Neck 27Esophageal Neoplasms 24Head and Neck Neoplasms 23Neoplasm Metastasis 22Esophageal Squamous Cell Carcinoma 16Carcinoma, Hepatocellular 16Adenocarcinoma Of Esophagus 16Parkinson Disease 4, Autosomal Dominant Lewy Body 14Neoplasms 11Nasopharyngeal Carcinoma 11Adenocarcinoma 7Urinary Bladder Neoplasms 5Keratosis, Actinic 5Cholangiocarcinoma 5Anus Neoplasms 5Intestinal Neoplasms 4Inflammatory Breast Neoplasms 4Hepatoblastoma 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Biliary Tract Neoplasms 4Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3HIV Infections 3

Interventions

apatinib 1Oxaliplatin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Apatinib × Fluorouracil × Clear all
NCT03365765 2023-02-14

mFOLFOX6 Chemotherapy With Apatinib as Postoperative Treatment in Stage IIIB or IIIC Colorectal Cancer

Huashan Hospital

Phase 3 Completed
63 enrolled

Apatinib

Data powered by HemOnc (CC BY 4.0) Colophon âš¡